Lactic acidosis in HIV-exposed infants with perinatal exposure to antiretroviral therapy

Annals of Tropical Paediatrics

Volumn 29, Issue 4, 2009, Pages 257-261

  Shah, Ira ^a  

^a B J WADIA HOSPITAL FOR CHILDREN   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; BICARBONATE; CARNITINE; CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; LACTIC ACID; LAMIVUDINE; NEVIRAPINE; RIBOFLAVIN; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STREPTOMYCIN; THIAMINE; UBIQUINONE; VIRUS RNA; ZIDOVUDINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; COUGHING; DEHYDRATION; DEVELOPMENTAL DISORDER; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FAILURE TO THRIVE; FEMALE; FEVER; FOLLOW UP; HEPATOSPLENOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTUBATION; JAUNDICE; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIVER DYSFUNCTION; LONG TERM EXPOSURE; LYMPHADENOPATHY; MENTAL DEFICIENCY; METABOLIC ACIDOSIS; PATIENT MONITORING; PERINATAL DRUG EXPOSURE; POLYMERASE CHAIN REACTION; POSITIVE END EXPIRATORY PRESSURE; PRENATAL CARE; PRENATAL EXPOSURE; QUADRIPLEGIA; SPASTICITY; TREATMENT RESPONSE; TUBERCULOUS LYMPHADENITIS; VIRUS LOAD;

ACIDOSIS, LACTIC; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 70849087607     PISSN: 02724936     EISSN: 14653281     Source Type: Journal    
DOI: 10.1179/027249309X12547917868880     Document Type: Article

References (10)

1. Brinkman K, ter Hofstede HJ. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: lactic acidosis, risk factors and therapeutic options. AIDS Review 1999; 1:141-148
2. Bolhaar MG, Karstaedt AS. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Clin Infect Dis 2007; 45:254-260
3. Casademont J, Barrientos A, Grau J, et al. The effect of ZVD on skeletal muscle mt DNA in HIV-1 infected patients with mild or no muscle dysfunction. Brain 1996; 119:1357-1364
4. Anderson T, Davidorich A, Feldman D, et al. Mitochondrial schwannopathy and peripheral myelinopathy in rabbit model of dideoxycitidine neurotoxicity. Lab Invest 1994; 70:724-739
5. Chariot P, Drogou I, De Lacroix-Szmania I, et al. ZVD-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J Hepatol 1999; 30:156-160
6. Verucchi G, Calza L, Biagetti C, et al. Ultrastructural liver mitochondrial abnormalities in HIV/HCV - coinfected patients receiving antiretroviral therapy. J Acquir Immune Defic Syndr 2004; 35:326-328
7. Noguera A, Fortuny C, Sanchez E, et al. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment. Pediatr Infect Dis J 2003; 22:778-782
8. Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Pediatr Infect Dis J 2003; 22:782-789
9. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999; 354:1084-1089 (Pubitemid 29452821)
10. Barret B, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction in HIV-1 exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 2003; 17:1769-1785